drugset / Trial / NCT02347358
Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke
Phase 2
Unknown
100 enrolled
The Second Artillery General Hospital
Hunan Rui Kang Tong technology development co., LTD · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to test a hypothesis that temporary implantation of JRecanTM blood flow recanalisation device within 6.5 hours of symptom onset of acute ischemic stroke due to a major intracranial artery occlusion following IV r-tPA can provide a greater rate of early successful recanalisation than treatment of IV r-tPA alone.
Timeline
- Start
- 2015-02
- Primary completion
- 2017-01
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alteplase | Protein / enzyme biologic | — | Intravenous |